Euclidean Capital as of March 31, 2026
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 10 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Intl Equity Index F Allwrld Ex Us (VEU) | 62.1 | $244M | 3.2M | 75.10 | |
| Vanguard Index Fds Value Etf (VTV) | 26.0 | $102M | 520k | 196.20 | |
| Ishares Tr Msci India Etf (INDA) | 4.4 | $17M | 370k | 46.84 | |
| Oric Pharmaceuticals (ORIC) | 3.2 | $13M | 989k | 12.67 | |
| Foghorn Therapeutics (FHTX) | 1.9 | $7.5M | 1.6M | 4.78 | |
| Pmv Pharmaceuticals (PMVP) | 0.8 | $3.3M | 2.6M | 1.24 | |
| Alector (ALEC) | 0.7 | $2.8M | 1.3M | 2.15 | |
| Surrozen Com New (SRZN) | 0.7 | $2.6M | 88k | 29.13 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $703k | 1.0M | 0.69 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.7k | 171k | 0.02 |
